HQH News and Press, Tekla Healthcare Investors From 04/13/21

I reveal two areas that I have invested half of my retirement funds into. I expect my hard-earned money to work as hard as I do, earning me more money. The main focus remains on high yield and recurrent income so I can enjoy my retirement. However, my new investment strategy t...

There are three primary things that I see a lot of newer CEF investors get hung up on; return of capital, section 19a and data aggregators distribution classifications. All three of these have to do with the tax character of the distributions and the mistakes that can be made. The...

In our opinion, telehealth will remain the leading segment of the internet healthcare market as the market shifts away from in-person medical visits. According to Apple CEO Tim Cook, “I believe, if you zoom out into the future, and you look back, and you ask the question, ...

Three High-Dividend picks that can provide outstanding income, turning a little capital into a growing income stream. We have included additional funds to make diversification easier. Get that monthly dividend check into your brokerage and enjoy the benefits. For further det...

Despite the big rally in the general markets, the healthcare sector has barely participated despite having strong tailwinds. Today, the healthcare sector is a "deep value" sector that each investor should have a good allocation. Billionaire investor Warren Buffett recently placed ...

Tekla Healthcare Investors' (HQH) board authorized a renewal of its share repurchase program enabling the fund to purchase in the open market up to 12% of its outstanding common shares for a one-year period ending July 14, 2022 (from earlier July 14, 2021). The share repurchase program i...

Let's say you are fully invested in the stock market, be they individual stocks or indexes. The S&P 500 and Dow Jones Industrial have been up nearly 80% since bottoming in March 2020, exactly a year ago. Are we heading into a new and prolonged bull-market, or are we heading bl...

Drugmakers are set to save the world from COVID-19 but their shares have lagged the broader market in the past year, making the group look like one of the best pockets of value in a richly priced stock market, Barron's reports.Drug stocks have not been so inexpensive relative to the S&P 5...

THW rights offering went ex-rights on March 5, 2021. An equal or better replacement in the form of THQ was readily available for those who wanted to sidestep the offering. Updated analysis for THW investors who have held through the ex-rights date. For further details see: ...

YYY has lost about 18% in share price since inception. It has also lost more than 30% in monthly distribution. This is before accounting for inflation. It may get worse in a rising rate environment. For further details see: YYY: Shrinking Value And Income